The investment giant behind WeWork isn’t afraid to make big, questionable-seeming bets. At the very least, though, SoftBank ...

Neither Y2K bust nor WeWork's failure deter SoftBank's mercurial chief Masayoshi Son to venture again into speculative ...

Fundraising is picking up among crypto venture funds after two dismal years, as investors hope to profit from the friendly ...

Swiss lender UBS is in talks to sell its hedge fund unit, O'Connor, to U.S. brokerage Cantor Fitzgerald, Bloomberg News reported on Thursday, citing people familiar with the matter.

Fintel reports that on May 7, 2025, Cantor Fitzgerald downgraded their outlook for Marvell Technology (NasdaqGS:MRVL) from ...

Cantor Fitzgerald is maintaining a bearish stance on equities, cautioning that the recent market rebound which has been driven largely by investor positioning—is likely behind us. The firm ...

Brandon Lutnick, son of U.S. Commerce Secretary Howard Lutnick and chair of brokerage Cantor Fitzgerald, revealed a multi-billion-dollar acquisition vehicle backed by crypto giants. The brokerage firm ...

UBS Group (NYSE:UBS) is in discussions to sell its O'Connor hedge fund unit to Cantor Fitzgerald. A potential deal may ...

UBS Group AG is in talks to sell its hedge fund unit O’Connor to Cantor Fitzgerald LP, a move that would end a more than ...

On Tuesday, Cantor Fitzgerald analyst Sarah James reaffirmed an Overweight rating on CVS Health (NYSE:CVS) with a steady price target of $71.00. The rating aligns with the company’s strong ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Travere Therapeutics (NASDAQ:TVTX), which has seen its stock surge 21.31% in the past week and an impressive 248.48% over the last ...